Our ethos, values and culture
What drives us
Driven by purpose. Guided by integrity
At Avanzanite, our ethos is rooted in doing the right thing - by patients, by partners, and by science.
We’re a purpose-led team that believes rare disease medicines deserve thoughtful, strategic access across every market.
Our culture is collaborative, focused, and grounded in a shared commitment to impact lives where it matters most.
Company culture and values
-
Who are we?
Ethos
We uncover potential. The hidden value in medicines and science behind. The opportunities in overlooked places. The quiet superpowers in people. And more… Because breakthrough impact and lasting legacy start with seeing what others don’t – and turning it into a bold, stimulating journey. A journey that sets new standards and creates our own path forward. And when it matters this much, it’s worth all our energy, our focus, and our talents.
-
Where do we direct our energy + talents?
Focus
Our journey starts with rare disease heroes — patients and biotech innovators. We focus on our continent, Europe, a 32-country labyrinth of complexity with huge gaps in patient access to orphan medicines, and missed opportunities for biotech innovators to impact lives and reward their efforts and risks. We stand with our heroes in our continent, breaking barriers to deliver life-changing orphan medicines to every corner in Europe.
-
What is our purpose?
Mission
With our novel pan-European partnership model, we aim to transform the way rare disease medicines are launched and reach patients in Europe – everywhere, from big countries to the smallest, leaving no community behind.
-
What do we consistently deliver?
Promise
No one left behind. Facing a rare disease is already hard enough – and the last thing any patient and their families should face is being unable to access the medicines that could give them hope.
-
What do we want to achieve?
Vision
By 2032, we’ll be Europe’s leader in commercialization of orphan medicines. Helping tens of thousands of patients with a strong catalogue of at least 10 life-changing rare disease medicines. We don’t just set goals. We are building a new blueprint – not just for where the industry is now, but for where it needs to go.
-
How do we plan to achieve that?
Strategy
We team up with biotech innovators in a bespoke way to unlock the full value of their rare disease medicines across all countries in Europe – navigating Europe’s complex landscape like master chess players.
“SOME WORDS HERE from an employee reinforcing the company culture, values and sharing how much of a joy it is to to part of the Avanzanite team. as we Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Dakota M Zarganis, Finance & HR Operations Manager